The predominant Quillaja Saponaria fraction, QS-18, is safe and effective when formulated in a liposomal murine cancer peptide vaccine
Shiqi Zhou, Yiting Song, Anoop Nilam, Yuan Luo, Wei‐Chiao Huang, Mark D. Long, Jonathan F. Lovell
Topics & Concepts
PharmacologyAdjuvantCD8ToxicityLiposomeImmune systemAntigenChemistryImmunologyBiologyBiochemistryOrganic chemistryImmunotherapy and Immune ResponsesImmune Response and Inflammationinterferon and immune responses